PRESCRIBING OF NONCONTRACEPTIVE ESTROGENS AND PROGESTINS IN THE UNITED-STATES, 1974-86

被引：133

作者：

HEMMINKI, E

KENNEDY, DL

BAUM, C

MCKINLAY, SM

机构：

[1] AMER INST RES,CAMBRIDGE RES CTR,CAMBRIDGE,MA

[2] US FDA,DIV EPIDEMIOL & SURVEILLANCE,ROCKVILLE,MD 20857

来源：

关键词：

D O I：

10.2105/AJPH.78.11.1479

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1478 / 1481

页数：4

共 12 条

[1] BARRETTCONNOR E, 1986, WESTERN J MED, V144, P620
[2] CONJUGATED ESTROGEN USE AND RISK OF ENDOMETRIAL CANCER
BURING, JE
BAIN, CJ
EHRMANN, RL
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 124 (03) : 434 - 441
[3] NONCONTRACEPTIVE ESTROGEN USE AND CARDIOVASCULAR-DISEASE
BUSH, TL
BARRETTCONNOR, E
[J]. EPIDEMIOLOGIC REVIEWS, 1985, 7 : 80 - 104
[4] KENNEDY DL, 1985, OBSTET GYNECOL, V65, P441
[5] PASLEY BH, 1984, PUBLIC HEALTH REP, V99, P424
[6] A PROSPECTIVE-STUDY OF POSTMENOPAUSAL ESTROGEN THERAPY AND CORONARY HEART-DISEASE
STAMPFER, MJ
WILLETT, WC
COLDITZ, GA
ROSNER, B
SPEIZER, FE
HENNEKENS, CH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (17) : 1044 - 1049
[7] POST-MARKETING STUDIES OF DRUG EFFICACY - WHY
STROM, BL
MELMON, KL
MIETTINEN, OS
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) : 475 - 480
[8] *US DEP COMM, 1983, GEN POP CHAR PC801B1, P1
[9] *US DEP COMM, 1980, POP EST PROJ P25, V875
[10] *US DEP COMM, 1986, STAT POP HOUS ES P25, V998